Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Brachytherapy|July 26, 2024
Comparison of perioperative and subacute postoperative complications between LDR and HDR monotherapy brachytherapy for prostate cancerPeter L Lee, Karen Ruth, Douglas Y Lee, et al.
Urologic Oncology|July 17, 2014
Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinomaReza Mehrazin, Robert G Uzzo, Alexander Kutikov, et al.
Computational Biology and Chemistry|August 24, 2025
Unlocking the anti-aging potential: In silico analysis of astaxanthin, curcumin, quercetin, and resveratrol in modulating skin aging pathwaysDebora Gonçalves Barbosa, Karen Ruth Michio Barbosa, Yasmin Moreto Guaitolini, et al.
The Canadian Journal of Urology|December 21, 2016
Patient reported outcomes among treatment modalities for prostate cancerMatthew E Johnson, Nicholas G Zaorsky, Jeffrey M Martin, et al.
Ophthalmic Epidemiology|May 5, 2016
Trachoma in Indigenous Settlements in Brazil, 2000-2008Helen Selma de Abreu Freitas, Norma Helen Medina, Maria de Fátima Costa Lopes, et al.
Clinical Colorectal Cancer|September 25, 2020
First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal CancerArthur Winer, Crystal S Denlinger, Namrata Vijayvergia, et al.
The Journal of Urology|January 11, 2023
Pathological and Clinical Outcomes in a Large Surveillance and Intervention Cohort of Radiographically Cystic Renal MassesRandall A Lee, Robert G Uzzo, Jordan Anaokar, et al.
Nature Communications|July 27, 2023
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumorsMatthew Zibelman, Alexander W MacFarlane, Kimberly Costello, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2022
Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 VaccineRebecca M Shulman, David S Weinberg, Eric A Ross, et al.
Frontiers in Oncology|September 3, 2024
Integrating frontiers: a holistic, quantum and evolutionary approach to conquering cancer through systems biology and multidisciplinary synergyMatheus Correia Casotti, Débora Dummer Meira, Aléxia Stefani Siqueira Zetum, et al.
Pageof 9